Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Resolution . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1100410A details a novel route for (+)-2-(3,4-dichlorophenyl)-4-hydroxybutylamine using N-methylglucamine resolution and borane reduction for high-purity tachykinin antagonists.
Patent CN101514163A reveals high-efficiency chiral resolution for Sibutramine. Offers supply chain stability and cost reduction for pharmaceutical intermediates.
Patent CN102101838A reveals a novel chiral resolution route for Mitiglinide Calcium, offering significant cost reduction and high purity for global API manufacturing supply chains.
Novel resolution method for S-indoline-2-carboxylic acid using amino acid esters. High purity, recyclable mother liquor, optimized for Perindopril synthesis.
Patent CN109400556A reveals cost-effective chiral resolution. Enhances supply chain stability for vitamin B5 manufacturers globally. Reliable sourcing for high-purity intermediates.
Patent CN113348163B reveals efficient route for ER+ cancer treatment intermediate ensuring supply continuity and cost optimization for global buyers.
Advanced synthesis of benzamide-substituted dioxocyclobutene intermediates via patent CN101514168B. Offers scalable routes, improved chiral purity, and cost-effective manufacturing for global supply chains.
Patent CN103864673B details a novel resolution and inversion route for chiral piperidine intermediates offering significant supply chain stability and cost reduction advantages for pharmaceutical manufacturing.
Patent CN102010327B details a cost-effective resolution method for S-(+)-Ketoprofen using a novel amine resolving agent, ensuring high optical purity and scalable manufacturing for pharmaceutical supply chains.
Patent CN104496936B details a high-purity Pramipexole synthesis using Red-Al reduction. This method offers significant cost reduction and supply chain reliability for API manufacturing.
Patent CN109863131A details high-purity chiral resolution. Offers supply chain reliability and cost reduction in pharma manufacturing for global partners.
Patent CN104496936B details high-purity Pramipexole synthesis using Red-Al. Offers supply chain stability and cost reduction in pharmaceutical manufacturing.
Advanced chiral resolution patent CN101195629B ensures high-purity D-biotin. Removes L-biotin impurities effectively for reliable pharmaceutical supply chains.
Advanced chiral resolution technology for 2-heterocyclic dihydropyrimidines using binaphthol phosphate. Delivers >99% optical purity for scalable hepatitis B drug manufacturing.
Patent CN102264715B reveals a scalable cinchonidine salt resolution process for HCV inhibitors, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN102417497A reveals a novel resolution method for Ramelteon intermediates, offering high optical purity and significant cost reduction in pharmaceutical manufacturing.
Advanced acetylation-crystallization method for D-Pantolactone resolution. Delivers 99.5% optical purity with significant cost reduction and stable supply chain capabilities.
This novel chiral resolution method offers high purity and significant cost efficiency for global pharmaceutical intermediate manufacturing supply chains today.
Patent CN1128785C reveals a novel two-step resolution process for high-purity 1-phenylethylamines, offering significant cost reduction and supply chain reliability for agrochemical manufacturing.
Patent CN108239091B details a robust chemical resolution for NLG919 precursors. This method offers high optical purity, recoverable reagents, and scalable manufacturing for pharmaceutical supply chains.